| 12359002 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2025-07-15 |
|
| 12152076 |
Bispecific and monospecific antibodies using novel anti-PD-1 sequences |
Matthew Bernett, Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon +1 more |
2024-11-26 |
$22,601,000 |
| 12129309 |
Heterodimeric antibodies that bind CD3 and CD38 |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid |
2024-10-29 |
$19,420,000 |
| 11945880 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2024-04-02 |
$13,323,000 |
| 11859011 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2024-01-02 |
$5,819,000 |
| 11673972 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2023-06-13 |
$14,580,000 |
| 11492407 |
Bispecific checkpoint inhibitor antibodies |
Matthew Bernett, Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon +1 more |
2022-11-08 |
$17,695,000 |
| 11472890 |
Heterodimeric antibodies that bind ENPP3 and CD3 |
Rumana Rashid, Gregory Moore, Alex Nisthal, Seung Chu, Sung-Hyung Lee +1 more |
2022-10-18 |
$15,176,000 |
| 11352442 |
Heterodimeric antibodies that bind CD3 and CD38 |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid |
2022-06-07 |
$5,744,000 |
| 11312770 |
Bispecific and monospecific antibodies using novel anti-PD-1 sequences |
Matthew Bernett, Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon +1 more |
2022-04-26 |
$13,039,000 |
| 11225528 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2022-01-18 |
$9,695,000 |
| 11111315 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2021-09-07 |
$18,929,000 |
| 10913803 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2021-02-09 |
$41,624,000 |
| 10889653 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2021-01-12 |
$38,787,000 |
| 10752678 |
Complement component C5 antibodies |
Peter C. Baciu, Yanbin Liang, Jason Guu, Matthew Bernett, John Desjarlais |
2020-08-25 |
|
| 10526417 |
Heterodimeric antibodies that bind CD3 and CD38 |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid |
2020-01-07 |
$22,955,000 |
| 10259887 |
Heterodimeric antibodies that bind CD3 and tumor antigens |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2019-04-16 |
$18,814,000 |
| 9932395 |
Nucleic acids encoding complement component C5 antibodies |
Peter C. Baciu, Yanbin Liang, Jason Guu, Matthew Bernett, John Desjarlais |
2018-04-03 |
|
| 9856327 |
Heterodimeric antibodies to CD3 X CD123 |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2018-01-02 |
$10,548,000 |
| 9850320 |
Heterodimeric antibodies to CD3 X CD20 |
Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more |
2017-12-26 |
$10,388,000 |
| 9701743 |
Complement component C5 antibodies |
Peter C. Baciu, Yanbin Liang, Jason Guu, Matthew Bernett, John Desjarlais |
2017-07-11 |
|
| 9040042 |
Optimized antibodies that target HM1.24 |
Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Duc-Hanh Thi Nguyen +1 more |
2015-05-26 |
$4,344,000 |
| 8394374 |
Optimized antibodies that target HM1.24 |
Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Duc-Hanh Thi Nguyen +1 more |
2013-03-12 |
|
| 7244823 |
TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
Bassil Dahiyat, John Desjarlais, Anton Filikov, Malu Tansey, Jonathan Zalevsky |
2007-07-17 |
|
| 7144987 |
Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders |
Arthur J. Chirino, Peizhi Luo, Peter Colon McDonnell, Malu Tansey |
2006-12-05 |
|
